Identification of two persistently activated neurotrophin-regulated pathways in rat hippocampus

Neuroscience

Volumn 95, Issue 3, 1999, Pages 705-719

  Blanquet, P R ^a  

^a INSERM   (France)

Author keywords

Brain derived neurotrophic factor; Hippocampus; Serine; Signal transduction; Synaptic plasticity; Threonine protein kinases

Indexed keywords

BINDING PROTEIN; BRAIN DERIVED NEUROTROPHIC FACTOR; CASEIN KINASE II; CYCLIC AMP; MITOGEN ACTIVATED PROTEIN KINASE; NEUROTROPHIN; PHOSPHOLIPASE; PROTEIN SERINE THREONINE KINASE; THREONINE PROTEINASE; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ARTICLE; AUTOPHOSPHORYLATION; DNA FLANKING REGION; ENZYME ACTIVATION; ENZYME ACTIVITY; GENETIC TRANSCRIPTION; HIPPOCAMPUS; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CALCIUM; CASEIN KINASE II; CYCLIC AMP; ENZYME ACTIVATION; HIPPOCAMPUS; ISOENZYMES; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; NEURAL PATHWAYS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-RAF; RATS; RATS, INBRED STRAINS;

EID: 0032761316     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(99)00489-3     Document Type: Article

References (100)

1. Abel T., Nguyen P.V., Barad M., Deuel T.A.S., Kandel E.R., Bourtchuladze R. Genetic demonstration of a role for PKA in the late phase of LTP and in hippocampus-based long-term memory. Cell. 88:1997;615-626.
2. Ackerman P., Osheroff N. Regulation of casein kinase 2 activity by epidermal growth factor in human A-431 carcinoma cells. J. biol. Chem. 264:1989;11,958-11,965.
3. Ackerman P., Glover C.V.C., Osheroff N. Stimulation of casein kinase 2 by epidermal growth factor: relationship between the physiological activity of the kinase and the phosphorylation state of its subunit. Proc. natn. Acad. Sci. U.S.A. 87:1990;821-825.
4. Agostinis P., Goris J., Pinna L.A., Merlevede W. Regulation of casein kinase 2 by phosphorylation/dephosphorylation. Biochem. J. 248:1987;785-789.
5. Akaneya Y., Tsumoto T., Hatanaka H. Brain-derived neurotrophic factor blocks long-term depression in rat visual cortex. J. Neurophysiol. 76:1996;4198-4201.
6. Barbacid M. Neurotrophic factors and their receptors. Curr. Opin. Cell Biol. 7:1995;148-155.
7. + current by a protein kinase-mediated mechanism. Neurosci. Lett. 112:1990;76-81.
8. 2+-dependent regulation in neuronal gene expression. Curr. Opin. Neurobiol. 7:1997;419-429.
9. 2+/calmodulin-dependent protein kinase 2 activity in hippocampus. J. biol. Chem. 272:1997;24,133-24,136.
10. Blanquet P.R. Neurotrophin-induced activation of casein kinase 2 in rat hippocampal slices. Neuroscience. 86:1998;739-749.
11. Blanquet P. R. (1999) Casein kinase 2 as a potentially important enzyme in the nervous system. Prog. Neurobiol. (in press).
12. Bonner T.I. Domains of muscarinic acetylcholine receptors that confer specificity of G protein coupling. Trends pharmac. Sci. 13:1992;48-50.
13. 2+/calmodulin-dependent protein kinase isoforms in rat brain. J. Neurosci. 15:1995;6797-6808.
14. Cabelli R.J., Hohn A., Shatz C.J. Inhibition of ocular dominance column formation by infusion of NT-4/5 or BDNF. Science. 267:1995;1662-1666.
15. Charriaut-Marlangue C., Otani S., Creuzet C., Ben-Ari Y., Loeb J. Rapid activation of hippocampal casein kinase 2 during long-term potentiation. Proc. natn. Acad. Sci. U.S.A. 88:1991;10,232-10,236.
16. Chawla S., Hardingham G.E., Quinn D.R., Bading H. CBP: a signal-regulated transcription coactivator controlled by nuclear calcium and CaM kinase 4. Science. 281:1998;1505-1509.
17. Churn S.B., Limbrick D., Sombati S., DeLorenzo R.J. Excitotoxic activation of the NMDA receptor results in inhibition of calcium/calmodulin kinase 2 activity in cultured hippocampal neurons. J. Neurosci. 15:1995;3200-3214.
18. Collatz M.B., Rüdel R., Brinkmeier H. Intracellular calcium chelator BAPTA protects cells against toxic calcium overload but also alters physiological calcium responses. Cell Calcium. 21:1997;453-459.
19. Dash P.K., Hochner B., Kandel E.R. Injection of the cAMP-responsive element into the nucleus of Aplysia sensory neurons blocks long-term facilitation. Nature. 345:1990;718-722.
20. 2+/calmodulin- as well as cAMP-dependent protein kinase. Proc. natn. Acad. Sci. U.S.A. 88:1991;5061-5065.
21. Derkinderen P., Enslen H., Girault J.-A. The ERK/MAP-kinase cascade in the nervous system. NeuroReport. 10:1999;R24-R34.
22. De Rooij J., Zwartkruis F.J.T., Verheijen M.H.G., Cool R.H., Nijman S.M.B., Wittinghofer A., Bos J.L. Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature. 396:1998;474-477.
23. Dudley D.T., Pang L., Decker S.J., Bridges A.J., Saltiel A.R. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. natn. Acad. Sci. U.S.A. 92:1995;7686-7689.
24. English D. Phosphatidic acid: a lipid messenger involved in intracellular and extracellular signalling. Cell Signal. 8:1996;341-347.
25. 2+/calmodulin-dependent protein kinase 4. Role in transcriptional regulation. J. biol. Chem. 269:1994;15,520-15,527.
26. Farooqui A.A., Yang H.-C., Rosenberger T.A., Horrocks L.A. Phospholipase A2 and its role in brain tissue. J. Neurochem. 69:1997;889-901.
27. Figurov A., Pozzo-Miller L.D., Olafson P., Wang T., Lu B. Regulation of synaptic responses to high-frequency stimulation and LTP by neurotrophins in the hippocampus. Nature. 381:1996;706-708.
28. Finkbeiner S., Tavazoie S., Maloratsky A., Jacobs K.M., Harris K.M., Greenberg M.E. CREB: a major mediator of neuronal neurotrophin responses. Neuron. 19:1997;1031-1047.
29. Fiore R.S., Bayer V.E., Pelech S.L., Posada J., Cooper J.A., Baraban J.M. p42 mitogen-activated protein kinase in brain: prominent localization in neuronal cell bodies and dentrites. Neuroscience. 55:1993;463-472.
30. Fukunaga K., Muller D., Miyamoto E. CaM kinase 2 in long-term potentiation. Neurochem. Int. 28:1996;343-358.
31. 286 of the calcium-calmodulin kinase 2 in LTP and learning. Science. 279:1998;870-872.
32. Hajimohammadreza I., Probert A.W., Coughenour L.L., Borosky S.A., Marcoux F.W., Boxer P.A., Wang K.W. A specific inhibitor of calcium/calmodulin-dependent protein kinase-2 provides neuroprotection against NMDA- and hypoxia/hypoglycemia-induced cell death. J. Neurosci. 15:1995;4093-4101.
33. Han J., Lee J.-D., Jiang Y., Li Z., Feng L., Ulevitch R.J. Characterization of the structure and function of a novel MAP kinase kinase (MKK6). J. biol. Chem. 271:1996;2886-2891.
34. 2+/calmodulin-dependent protein kinases. A. Rev. Biochem. 61:1992;559-601.
35. 2+/calmodulin-dependent protein kinase 2 blocks its nuclear targeting. J. biol. Chem. 273:1998;19,763-19,771.
36. Herdegen T., Leah J.D. Inducible and constitutive transcription factors in the mammalian nervous system: control of gene expression by Jun, Fos and Krox, and CREB/ATF proteins. Brain Res. Rev. 28:1998;370-490.
37. Hu B.R., Wieloch T. Casein kinase 2 activity in the postischemic rat brain increases in brain regions resistant to ischemia and decreases in vulnerable areas. J. Neurochem. 60:1993;1722-1728.
38. 2+/calmodulin-dependent protein kinase 2 and its messenger RNA in the rat hippocampus following normo- and hypothermic ischemia. Neuroscience. 68:1995;1003-1016.
39. 2+/calmodulin-dependent protein kinase 2 in the crude synaptosomal fraction of the vulnerable hippocampus following hypoglycemia. J. Neurochem. 64:1995;1361-1369.
40. Izquierdo I., Medina J.H. Memory formation: the sequence of biochemical events in the hippocampus and its connection to activity in other brain structures. Neurobiol. Learn. Mem. 68:1997;285-316.
41. ras. Molec. cell. Biol. 14:1994;6944-6953.
42. Kang H.J., Schulman E.M. Long-lasting neurotrophin-induced enhancement of synaptic transmission in the adult hippocampus. Science. 267:1995;1658-1662.
43. Kiss Z., Tomono M. Compound D609 inhibits phorbol ester-stimulated phospholipase D activity and phospholipase C-mediated phosphatidylethanolamine hydrolysis. Biochim. biophys. Acta. 1259:1995;105-108.
44. Kramer R.M., Roberts E.F., Um S.L., Börsch-Haubold A.G., Watson S.P., Fisher M.J., Jakubowski J.A. p38 mitogen-activated protein kinase phosphorylates cytosolic phospholipase A2 (cPLA2) in thrombin-stimulated platelets. J. biol. Chem. 271:1996;27,723-27,729.
45. Kumar S., McDonnell P.C., Gum R.J., Hand A.T., Lee J.C., Young P.R. Novel homologues of CSBP: p38 MAP kinase: activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles. Biochem. biophys. Res. Commun. 235:1997;533-538.
46. Kyriakis J.M., Avruch J. Sounding the alarm: protein kinase cascades activated by stress and inflammation. J. biol. Chem. 271:1996;24,313-24,316.
47. Lee J.C., Laydon J.T., McDonnell P.C., Gallagher T.F., Kumar S., Green D., McNulty D., Blumenthal M.J., Heys J.R., Landvatter S.W., Strickler J.E., McLaughlin M.M., Siemens I.R., Fisher S.M., Livi G.P., White J.R., Adams J.L., Young P.R. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature. 372:1994;739-746.
48. Levine E.S., Dreyfus C.F., Black I.B., Plummer M.R. Selective role for trkB neurotrophin receptors in rapid modulation of hippocampal synaptic transmission. Molec. Brain Res. 38:1996;300-303.
49. Lisman J. The CaM kinase 2 hypothesis for the storage of synaptic memory. Trends Neurosci. 17:1994;406-409.
50. A receptor. J. Neurochem. 61:1993;375-377.
51. Marsh H.N., Palfrey H.C. Neurotrophin-3 and brain-derived neurotrophic factor activate multiple signal transduction events but are not survival factors for hippocampal pyramidal neurons. J. Neurochem. 67:1996;952-963.
52. Marshall C.J. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell. 80:1995;179-185.
53. McGahon B., Lynch M.A. Analysis of the interaction between arachidonic acid and metabotropic glutamate receptor activation reveals that phospholipase C acts as a coincidence detector in the expression of long-term potentiation in the rat dentate gyrus. Hippocampus. 8:1998;48-56.
54. Meggio F., Brunati A.M., Pinna L.A. Autophosphorylation of type 2 casein kinase TS at both its α- and β-subunits. Fedn Eur. biochem. Socs Lett. 160:1983;203-208.
55. Mons N., Cooper D.M.F. Adenylate cyclases: critical foci in neuronal signaling. Trends Neurosci. 18:1995;536-542.
56. Morooka T., Nishida E. Requirement of p38 mitogen-activated protein kinase for neuronal differentiation in PC12 cells. J. biol. Chem. 273:1998;24,285-24,288.
57. Mulner-Lorillon O., Cormier P., Labbé J.-C., Dorée M., Poulhe R., Osborne H.G., Bellé R. M-phase-specific cdc2 protein kinase phosphorylates the β subunit of casein kinase 2 and increases casein kinase 2 activity. Eur. J. Biochem. 193:1990;529-534.
58. Murphy T.H., Blatter L.A., Bhat R.V., Fiore R.S., Wier W.G., Barabar J.M. Differential regulation of calcium/calmodulin-dependent protein kinase 2 and p42 MAP kinase activity by synaptic transmission. J. Neurosci. 14:1994;1320-1331.
59. Murray B., Alessandrini A., Cole A.J., Yee A.G., Furshpan E.J. Inhibition of the p44/42 MAP kinase pathway protects hippocampal neurons in a cell-culture model of seizure activity. Proc. natn. Acad. Sci. U.S.A. 95:1998;11,975-11,980.
60. Nakanishi S. Metabotropic glutamate receptors: synaptic transmission, modulation, and plasticity. Neuron. 13:1994;1031-1037.
61. 2+/calmodulin-dependent protein kinase 2 phosphorylation of the presynaptic protein synapsin 1 is persistently increased during long-term potentiation. Proc. natn. Acad. Sci. U.S.A. 93:1996;15,451-15,456.
62. Nemoto S., Xiang J.L., Huang S., Lin A.N. Induction of apoptosis by SB202190 through inhibition of p38 beta mitogen-activated protein kinase. J. biol. Chem. 273:1998;16,415-16,420.
63. Nguyen P.V., Abel T., Kandel E.R. Requirement of a critical period of transcription for induction of a late phase of LTP. Science. 265:1994;1104-1107.
64. Nichols R.A., Sihra T.S., Czernik A.J., Nairn A.C., Greengard P. Calcium/calmodulin-dependent protein kinase 2 increases glutamate and noradrenaline release from synaptosomes. Nature. 343:1990;647-651.
65. 2+-stimulated adenylyl cyclases by Gi-coupled receptors in vivo. J. biol. Chem. 271:1996;33,308-33,316.
66. 2+/calmodulin-dependent kinase in intact hippocampal slices. Neuron. 6:1991;907-914.
67. Ohmichi M., Pang L., Ribon V., Gazit A., Levitzki A., Saltiel A.L. The tyrosine kinase inhibitor tyrphostin blocks the cellular actions of nerve growth factor. Biochemistry. 32:1993;4650-4658.
68. Orban P.C., Chapman P.F., Brambilla R. Is the Ras-MAPK signalling pathway necessary for long-term memory formation? Trends Neurosci. 22:1999;38-44.
69. Ouyang Y., Kantor D., Harris K.M., Schuman E.M., Kennedy M.B. Visualization of the distribution of autophosphorylated calcium/calmodulin-dependent protein kinase 2 after tetanic stimulation in the CA1 area of the hippocampus. J. Neurosci. 15:1997;5416-5427.
70. Patterson S.L., Abel T., Deuel T.A.S., Martin K.C., Rose J.C., Kandel E.R. Recombinant BDNF rescues deficits in basal synaptic transmission and hippocampal LTP in BDNF knockout mice. Neuron. 16:1996;1137-1145.
71. Plevin R., Malarkey K., Aidulis D., McLees A., Gould G.W. Cyclic AMP inhibits PDGF-stimulated mitogen-activated protein kinase activity in rat aortic smooth muscle cells via inactivation of c-Raf-1 kinase and induction of MAP kinase phosphatase-1. Cell Signal. 9:1997;323-328.
72. Raingeaud J., Whitmarsh A.J., Barrett T., Derijard B., Davis R.J. MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Molec. cell. Biol. 16:1996;1247-1255.
73. Rizzo M.A., Shome K., Vasudevan C., Stolz D.B., Sung T.-C., Frohman M.A., Watkins S.C., Romero G. Phospholipase D and its product, phosphatidic acid, mediate agonist-dependent Raf-1 translocation to the plasma membrane and the activation of the mitogen-activated protein kinase pathway. J. biol. Chem. 274:1999;1131-1139.
74. Russell M., Winitz S., Johnson G.L. Acetylcholine muscarinic m1 receptor regulation of cyclic AMP synthesis controls growth factor stimulation of Raf activity. Molec. cell. Biol. 14:1994;2343-2351.
75. 2+ oscillations in cultured hippocampal neurons. Brain Res. 778:1997;318-328.
76. Schafe G.E., Nadel N.V., Sullivan G.M., Harris A., LeDoux J.E. Memory consolidation for contextual and auditory fear conditioning is dependent on protein synthesis, PKA, and MAP kinase. Learn. Mem. 6:1999;97-110.
77. Schmidt-Kastner R., Wetmore C., Olson L. Comparative study of brain-derived neurotrophic factor messenger RNA and protein at the cellular level suggests multiple roles in hippocampus, striatum and cortex. Neuroscience. 74:1996;161-183.
78. Schulman H. Protein phosphorylation in neuronal plasticity and gene expression. Curr. Opin. Neurobiol. 5:1995;375-381.
79. Schütze S., Potthoff K., Machleidt T., Berkovic D., Wiegmann K., Krönke M. TPN activates NF-κB by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown. Cell. 71:1992;765-776.
80. Shen K., Teruel M.N., Subramanian K., Meyer T. CaMK2 beta functions as an F-actin targeting module that localizes CaMK2 alpha/beta heterooligomers to dentritic spines. Neuron. 21:1998;593-606.
81. Shieh P.B., Hu S.-C., Bobb K., Timmusk T., Ghosh A. Identification of a signaling pathway involved in calcium regulation of BDNF expression. Neuron. 20:1998;727-740.
82. Shimomura A., Ogawa Y., Kitani T., Fujisawa H., Hagiwara M. Calmodulin-dependent protein kinase 2 potentiates transcriptional activation through activating transcription factor 1 but not cAMP response element-binding protein. J. biol. Chem. 271:1996;17,957-17,960.
83. Smith R.J., Sam L.M., Justen J.M., Bundy G.L., Bala G.A., Bleasdale J.E. Receptor-coupled signal transduction in human polymorphonuclear neutrophils: effects of a novel inhibitor of phospholipase C-dependent processes on cell responsiveness. J. Pharmac. exp. Ther. 253:1990;688-697.
84. Soderling T.R. Modulation of glutamate receptors by calcium/calmodulin-dependent protein kinase 2. Neurochem. Int. 28:1996;359-361.
85. Song D.-K., Choe B.-K., Bae J.H., Park W.K., Han I.S., Ho W.-K., Earm Y.E. Brain-derived neurotrophic factor rapidly potentiates synaptic transmission through NMDA, but suppresses it through non-NMDA receptor in rat hippocampal neuron. Brain Res. 799:1998;176-179.
86. Stephens R.M., Loeb D.M., Copeland T.D., Pawson T., Greene L.A., Kaplan D.R. Trk receptors use redundant signal transduction pathways involving SHC and PLC-γ1 to mediate NGF responses. Neuron. 12:1994;691-705.
87. Stokoe D., Caudwell B., Cohen P.T.W., Cohen P. The substrate specificity and structure of mitogen-activated protein (MAP) kinase-activated protein kinase-2. Biochem. J. 296:1993;843-849.
88. Strack S., Choi S., Lovinger D.M., Colbran R.J. Translocation of autophosphorylated calcium/calmodulin-dependent protein kinase 2 to the postsynaptic density. J. biol. Chem. 272:1997;13,467-13,470.
89. 2+/calmodulin-dependent protein kinases type 1, 2, and 4. J. biol. Chem. 271:1996;3066-3073.
90. Tan Y., Rouse J., Zhang A., Cariati S., Cohen P., Comb M.J. FGF and stress regulate CREB and ATF-1 via a pathway involving p38 MAP kinase and MAPKAP kinase-2. Eur. molec. Biol. Org. J. 15:1996;4629-4642.
91. Thoenen H. Neurotrophins and neuronal plasticity. Science. 270:1995;593-597.
92. 2+/calmodulin-dependent protein kinase 2. J. biol. Chem. 265:1990;4315-4320.
93. Tsumoto T., Yasuda H. A switching role of postsynaptic calcium in the induction of long-term potentiation or long-term depression in visual cortex. The Neurosciences. 8:1996;311-319.
94. Vojtek A.B., Cooper J.A. Rho family members: activators of MAP kinase cascades. Cell. 82:1995;527-529.
95. Weisskopf M.G., Castillo P.E., Zalutsky R.A., Nicoll R.A. Mediation of hippocampal mossy fiber long-term potentiation by cyclic AMP. Science. 265:1994;1878-1882.
96. Willingham D.B. Systems of memory in the human brain. Neuron. 18:1997;5-8.
97. Wu K., Xu J.L., Suen P.C., Levine E., Huang Y.Y., Mount H.T.J., Lin S.Y.I., Black I.B. Functional trkB neurotrophin receptors are intrinsic components of the adult brain postsynaptic density. Molec. Brain Res. 43:1996;286-290.
98. Xing J., Kornhauser J.M., Xia Z., Thiele E.A., Greenberg M.E. Nerve growth factor activates extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways to stimulate CREB serine 133 phosphorylation. Molec. cell. Biol. 18:1998;1946-1955.
99. 2+/calmodulin-dependent protein kinase 2 by acute neuronal excitation in vivo. J. Neurochem. 71:1998;427-439.
100. York R.D., Yao H., Dillon T., Ellig C.L., Eckert S.P., McCleskey E.W., Stork P.J.S. Rap1 mediates sustained MAP kinase activation induced by nerve growth factor. Nature. 392:1998;622-626.